The Australian Research Data Commons (ARDC) invites you to participate in a short survey about your
interaction with the ARDC and use of our national research infrastructure and services. The survey will take
approximately 5 minutes and is anonymous. It’s open to anyone who uses our digital research infrastructure
services including Reasearch Link Australia.
We will use the information you provide to improve the national research infrastructure and services we
deliver and to report on user satisfaction to the Australian Government’s National Collaborative Research
Infrastructure Strategy (NCRIS) program.
Please take a few minutes to provide your input. The survey closes COB Friday 29 May 2026.
Complete the 5 min survey now by clicking on the link below.
The Role Of Angiotensin-(1-7), Angiotensin Converting Enzyme-2 And The Mas Receptor In Liver Fibrosis And The Development And Maintenance Of Portal Hypertension
Funder
National Health and Medical Research Council
Funding Amount
$55,575.00
Summary
Chronic liver disease is widespread in our community, and is increasing due to fatty liver disease and viral hepatitis. Liver disease leads to permanent liver scarring, liver cancer and other life-threatening complications. This research investigates the role of a hormone system called the renin-angiotensin system in liver disease, and investigated the use of drugs that act on this system for the prevention and treatment of liver scarring and these complications.
Transient Receptor Potential Calcium Channels In Breast Cancer Cell Proliferation, Apoptosis And Invasiveness
Funder
National Health and Medical Research Council
Funding Amount
$104,018.00
Summary
Calcium is a highly regulated signal used by cells to control processes such as growth and division, cell death and motility. Calcium channels let calcium into the cells, and specific calcium channel types are overexpressed in cancers, including those of the prostate and breast. In this research, we will assess the role of specific calcium permeable channels known as TRPs in breast cancer and the consequences of their inhibition on breast cancer cell growth and survival.